公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
公司地址 5401 West Kennedy Boulevard, Suite 890, Tampa, FL, USA, 33609
電話號碼 +1 813 553-6680
傳真號碼 --
公司網頁 https://www.pacira.com
員工數量 829
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Brendan P. Teehan Chief Commercial Officer -- 21/01/2025
Mr. Frank D. Lee Director and Chief Executive Officer 美元 896.54K 26/02/2026
Mr. Jonathan Slonin Chief Medical Officer 美元 535.00K 29/04/2025
Mr. Shawn M. Cross Chief Financial Officer 美元 100.96K 26/02/2026
Mr. Daryl Gaugler Executive Vice President, Commercial Operations 美元 511.81K 21/01/2025
Ms. Lauren Riker Principal Accounting Officer and Senior Vice President, Finance 美元 374.56K 26/02/2026
Ms. Kristen Marie Williams Chief Administrative Officer and Secretary 美元 519.26K 29/04/2025
Ms. Krys Corbett Chief Business Officer -- 21/01/2025
 
董事會成員
董事會 職務 更新日期
Ms. Laura A. Brege Chairman of the Board 26/02/2026
Mr. Frank D. Lee Director and Chief Executive Officer 26/02/2026
Mr. Michael J. Yang Independent Director 26/02/2026
Dr. Marcelo Bigal, M.D.,PhD Independent Director 26/02/2026
Dr. Mark I. Froimson, M.D. Independent Director 26/02/2026
Ms. Alethia Young Independent Director 26/02/2026
Dr. Samit Hirawat, M.D. Independent Director 28/01/2026
Governor Christopher J. Christie Independent Director 26/02/2026
Mr. Abraham N. Ceesay, M.B.A. Independent Director 26/02/2026
Dr. Mark A. Kronenfeld, M.D. Independent Director 26/02/2026
 
所屬ETF (更新日期: 07/03/2026 04:57)
代號 名稱 佔比% 持有日期
SQLVRoyce Quant Small-Cap Quality Value ETF0.01%27/02/2026
WSMLiShares MSCI World Small-Cap ETF0.01%28/02/2026
XJRiShares ESG Select Scrn S&P Small-CapETF0.01%28/02/2026
VTWGVanguard Russell 2000 Growth ETF0.01%31/01/2026
VTHRVanguard Russell 3000 ETF0.01%31/01/2026
QQQSInvesco NASDAQ Future Gen 200 ETF0.01%27/02/2026
UWMProShares Ultra Russell20000.01%27/02/2026
URTYProShares UltraPro Russell20000.01%27/02/2026
FLQSFranklin US Small Cap Mltfctr Idx ETF0.01%28/02/2026
IBBQInvesco Nasdaq Biotechnology ETF0.01%27/02/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.005%28/02/2026
BIBProShares Ultra Nasdaq Biotechnology0.005%27/02/2026
AVSUAvantis Responsible US Equity ETF0.005%28/02/2026
ISCBiShares Morningstar Small-Cap ETF0.005%28/02/2026
ITWOProShares Russell 2000 High Income ETF0.005%27/02/2026
FTKIFirst Trust Small Cp BuyWrt Inc ETF0.005%26/02/2026
FNDBSchwab Fundamental U.S. Broad Market ETF0.003%28/02/2026
ACSVAmerican Century Small Cp Val Insgts ETF0.003%28/02/2026
DXUVDimensional US Vector Equity ETF0.003%27/02/2026
RFLRInnovator U.S. Small Cp Mgd Flr ETF0.003%25/02/2026
  1    2    3   4    5    6  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.